Historically characterized by excessive daytime sleepiness and cataplexy, narcolepsy is increasingly recognized as a ...
Current sickle cell disease (SCD) trial eligibility criteria exclude most adults, with only 9.9% meeting inclusion thresholds ...
EHA 2026 highlights included practice-changing immunotherapy data in relapsed/refractory multiple myeloma and high-risk pediatric B-cell ALL, plus insights on childhood cancer predisposition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results